Phio Pharmaceuticals
PHIO
#10951
Rank
HK$69.02 M
Marketcap
HK$5.78
Share price
-4.54%
Change (1 day)
-43.70%
Change (1 year)

EPS for Phio Pharmaceuticals (PHIO)

EPS in 2026 (TTM): -HK$12.44

According to Phio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$12.47. In 2019 the company made an earnings per share (EPS) of -HK$16,392 an increase over its 2018 EPS that were of -HK$79,313.

EPS history for Phio Pharmaceuticals from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$12.44
2019-HK$16,392-79.33%
2018-HK$79,313-68.67%
2017-HK$253,126-59.96%
2016-HK$632,109-36.54%
2015-HK$996,142-72.99%
2014-HK$3,688,595

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-HK$1.49-88.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-HK$7.45-40.25%๐Ÿ‡บ๐Ÿ‡ธ USA